169 related articles for article (PubMed ID: 16951315)
1. Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene.
Shibata S; Okano S; Yonemitsu Y; Onimaru M; Sata S; Nagata-Takeshita H; Inoue M; Zhu T; Hasegawa M; Moroi Y; Furue M; Sueishi K
J Immunol; 2006 Sep; 177(6):3564-76. PubMed ID: 16951315
[TBL] [Abstract][Full Text] [Related]
2. RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer.
Kato T; Ueda Y; Kinoh H; Yoneyama Y; Matsunaga A; Komaru A; Harada Y; Suzuki H; Komiya A; Shibata S; Hasegawa M; Hayashi H; Ichikawa T; Yonemitsu Y
Neoplasia; 2010 Nov; 12(11):906-14. PubMed ID: 21076616
[TBL] [Abstract][Full Text] [Related]
3. Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells.
Yoneyama Y; Ueda Y; Akutsu Y; Matsunaga A; Shimada H; Kato T; Kubota-Akizawa M; Okano S; Shibata S; Sueishi K; Hasegawa M; Ochiai T; Yonemitsu Y
Biochem Biophys Res Commun; 2007 Mar; 355(1):129-35. PubMed ID: 17292867
[TBL] [Abstract][Full Text] [Related]
4. Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen.
Yonemitsu Y; Ueda Y; Kinoh H; Hasegawa M
Front Biosci; 2008 May; 13():4953-9. PubMed ID: 18508560
[TBL] [Abstract][Full Text] [Related]
5. Complete elimination of established neuroblastoma by synergistic action of gamma-irradiation and DCs treated with rSeV expressing interferon-beta gene.
Tatsuta K; Tanaka S; Tajiri T; Shibata S; Komaru A; Ueda Y; Inoue M; Hasegawa M; Suita S; Sueishi K; Taguchi T; Yonemitsu Y
Gene Ther; 2009 Feb; 16(2):240-51. PubMed ID: 18987675
[TBL] [Abstract][Full Text] [Related]
6. Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen.
Yonemitsu Y; Ueda Y; Kinoh H; Hasegawa M
Front Biosci; 2008 Jan; 13():1892-8. PubMed ID: 17981677
[TBL] [Abstract][Full Text] [Related]
7. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus.
Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y
J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206
[TBL] [Abstract][Full Text] [Related]
8. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.
Hiraoka K; Yamamoto S; Otsuru S; Nakai S; Tamai K; Morishita R; Ogihara T; Kaneda Y
J Immunol; 2004 Oct; 173(7):4297-307. PubMed ID: 15383558
[TBL] [Abstract][Full Text] [Related]
9. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
[TBL] [Abstract][Full Text] [Related]
10. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
[TBL] [Abstract][Full Text] [Related]
11. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
Wang J; Saffold S; Cao X; Krauss J; Chen W
J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated antigen/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immunosuppressive cells in metastatic melanoma.
Aravindaram K; Wang PH; Yin SY; Yang NS
Gene Ther; 2014 May; 21(5):457-67. PubMed ID: 24572790
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral injection of interferon-gamma gene-modified dendritic cells elicits potent antitumor effects: effective induction of tumor-specific CD8+ CTL response.
Pan J; Zhang M; Wang J; Wang Q; Xia D; Sun W; Zhang L; Yu H; Cao X
J Cancer Res Clin Oncol; 2005 Jul; 131(7):468-78. PubMed ID: 15711825
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.
Asavaroengchai W; Kotera Y; Koike N; Pilon-Thomas S; Mulé JJ
Biol Blood Marrow Transplant; 2004 Aug; 10(8):524-33. PubMed ID: 15282530
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
[TBL] [Abstract][Full Text] [Related]
17. TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses.
López CB; Moltedo B; Alexopoulou L; Bonifaz L; Flavell RA; Moran TM
J Immunol; 2004 Dec; 173(11):6882-9. PubMed ID: 15557183
[TBL] [Abstract][Full Text] [Related]
18. TLR7 ligand augments GM-CSF-initiated antitumor immunity through activation of plasmacytoid dendritic cells.
Narusawa M; Inoue H; Sakamoto C; Matsumura Y; Takahashi A; Inoue T; Watanabe A; Miyamoto S; Miura Y; Hijikata Y; Tanaka Y; Inoue M; Takayama K; Okazaki T; Hasegawa M; Nakanishi Y; Tani K
Cancer Immunol Res; 2014 Jun; 2(6):568-80. PubMed ID: 24830413
[TBL] [Abstract][Full Text] [Related]
19. Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells.
Hosoya N; Miura T; Kawana-Tachikawa A; Koibuchi T; Shioda T; Odawara T; Nakamura T; Kitamura Y; Kano M; Kato A; Hasegawa M; Nagai Y; Iwamoto A
J Med Virol; 2008 Mar; 80(3):373-82. PubMed ID: 18205221
[TBL] [Abstract][Full Text] [Related]
20. Highly immunostimulatory RNA derived from a Sendai virus defective viral genome.
Mercado-López X; Cotter CR; Kim WK; Sun Y; Muñoz L; Tapia K; López CB
Vaccine; 2013 Nov; 31(48):5713-21. PubMed ID: 24099876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
